BRIACELL THERAPEUTICS CORP BCTXW
*W EXP 02/24/202 · Equity WRT · CUSIP 10778Y112
8
institutional holders
-1 vs Q1 2022
1.4m
shares reported held*
$3.6mreported value*
1 new
3 added
0 reduced
2 sold out
net bought ≈ $634.7k (+244.1k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.60.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 7 |
| Q2 2021 | 11 |
| Q3 2021 | 9 |
| Q4 2021 | 6 |
| Q1 2022 | 9 |
| Q2 2022 | 8 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2021 | 4 | 4 |
| Q3 2021 | 3 | 5 |
| Q4 2021 | 1 | 4 |
| Q1 2022 | 5 | 0 |
| Q2 2022 | 4 | 2 |
Biggest buyers
| Privium Fund Management B.V. | New | +194.8k |
| Murchinson Ltd. | Added | +56.3k |
| K.J. Harrison & Partners Inc | Added | +21.2k |
| UBS Group AG | Added | +3.9k |
Biggest sellers
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -16.1k |
| Warberg Asset Management LLC | Sold out | -16.0k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Murchinson Ltd. 0.26% of their portfolio | 526.2k $1.4m | Added +56.3k |
| ARMISTICE CAPITAL, LLC 0.02% of their portfolio | 375.0k $975.0k | Unchanged |
| Privium Fund Management B.V. 0.17% of their portfolio | 194.8k $507.0k | New |
| K.J. Harrison & Partners Inc 0.13% of their portfolio | 181.3k $472.0k | Added +21.2k |
| Redmond Asset Management, LLC 0.07% of their portfolio | 75.0k $190.0k | Unchanged |
| ZEKE CAPITAL ADVISORS, LLC 0.01% of their portfolio | 45.0k $117.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 5.1k $13.0k | Added +3.9k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |